people
Dr. Jang-Moo Lee, the incumbent Chairman of the KAIST Board of Trustees, has been re-elected to head the office. His term will begin from the date of approval by the Minister of Science, ICT and Future Planning of Korea and will last for three years.
Dr. Lee received his undergraduate and master’s degrees in mechanical engineering from Seoul National University. He later earned his doctoral degree in mechanical engineering from Iowa State University in the United States.
Joined the faculty of his alma mater in 1976, Dr. Lee held various posts within the university including the dean of the engineering college. He served as the president of the Association of Korean Engineering Colleges, the founding chairman of the Korea Evaluation Institute of Industrial Technology, the president of the Korean Society of Mechanical Engineers, the 24th president of Seoul National University, and the 13th president of the Korean Council for University Education. He now serves as the president of the National Science and Technology Council of Korea and the chairman of Climate Change Center’s Board of Directors.
Dr. Lee has received numerous honors and awards, among others, the Academic Award of the Korean Society of Mechanical Engineers (1985), the Order of Science and Technology Merit from the Korean government (2005), the National Academy of Sciences Award (2005), and the Order of Service Merit in Blue Stripes (2010) from the Korean government. He was also selected as the Alma Mater Proud from Kyunggi High School in 2011.
-
research Revolutionary 'scLENS' Unveiled to Decode Complex Single-Cell Genomic Data
Unlocking biological information from complex single-cell genomic data has just become easier and more precise, thanks to the innovative 'scLENS' tool developed by the Biomedical Mathematics Group within the IBS Center for Mathematical and Computational Sciences led by Chief Investigator Jae Kyoung Kim, who is also a professor at KAIST. This new finding represents a significant leap forward in the field of single-cell transcriptomics. Single-cell genomic analysis is an advanced technique that m
2024-05-09 -
research KAIST Develops Sodium Battery Capable of Rapid Charging in Just a Few Seconds
Sodium (Na), which is over 500 times more abundant than lithium (Li), has recently garnered significant attention for its potential in sodium-ion battery technologies. However, existing sodium-ion batteries face fundamental limitations, including lower power output, constrained storage properties, and longer charging times, necessitating the development of next-generation energy storage materials. On the 11th of April, KAIST (represented by President Kwang Hyung Lee) announced that a research t
2024-04-18 -
research KAIST introduces microbial food as a strategy food production of the future
The global food crisis is increasing due to rapid population growth and declining food productivity to climate change. Moreover, today's food production and supply system emit a huge amount of carbon dioxide, reaching 30% of the total amount emitted by humanity, aggravating climate change. Sustainable and nutritious microbial food is attracting attention as a key to overcoming this impasse. KAIST (President Kwang Hyung Lee) announced on April 12th that Research Professor Kyeong Rok Choi of th
2024-04-12 -
research KAIST researchers developed a novel ultra-low power memory for neuromorphic computing
A team of Korean researchers is making headlines by developing a new memory device that can be used to replace existing memory or used in implementing neuromorphic computing for next-generation artificial intelligence hardware for its low processing costs and its ultra-low power consumption. KAIST (President Kwang-Hyung Lee) announced on April 4th that Professor Shinhyun Choi's research team in the School of Electrical Engineering has developed a next-generation phase change memory* device fe
2024-04-04 -
research A KAIST-SNUH Team Devises a Way to Make Mathematical Predictions to find Metabolites Related to Somatic Mutations in Cancers
Cancer is characterized by abnormal metabolic processes different from those of normal cells. Therefore, cancer metabolism has been extensively studied to develop effective diagnosis and treatment strategies. Notable achievements of cancer metabolism studies include the discovery of oncometabolites* and the approval of anticancer drugs by the U.S. Food and Drug Administration (FDA) that target enzymes associated with oncometabolites. Approved anticancer drugs such as ‘Tibsovo (active ingre
2024-03-18